跳至主要内容
临床试验/IRCT20180620040164N60
IRCT20180620040164N60尚未招募Unknown

Comparative bioequivalence study of Desloratadine 5 mg Tablet of ActoverCo. and Aerius of Merk as reference in 24 healthy male under fasting.

Actover Pharmaceutical Co.0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 45 years(—)
性别
Male

入选标准

  • Healthy subjects (male) should be between 20-45 years old.
  • subjects how have body mass index (BMI) Within 15% of normal range between 18.5-30 (Kg/m2)
  • Subjects must not have a historical specific diseases or abnormal values in labratory tests and general clinical examination.
  • Subjects with normal vital signs.
  • Subjects who agree with patient consent form.

排除标准

  • Subjects with known allergy to the products tested.
  • Smoking more than 10 cigarettes per day and could not tolerate cigarette cessation during each clinical period.
  • Subjects who has used any prescription or OTC drugs 14 days prior to the initiation of study and unable to refrain from the concomitant medications.
  • History of alcohol or drug abuse.
  • Heavy drinker of caffeine, grapefruit juice or caffeinated drinks or who are on special diet (such as vegetarians) or do exertional physical activity.
  • A history of difficulty with donating blood or donation of more than 500 ml blood within 7 days prior to the start of the study.

研究者

发起方
Actover Pharmaceutical Co.

相似试验

Comparative in vivo evaluation of 2 Desloratadine 5... | 临床试验